Alzheimer's Disease Diagnostics Must Be Globally Accessible

Area of Science:

• Neuroscience
• Global Health
• Medical Technology

Background:

• Dementia and Alzheimer's disease (AD) represent a growing global health challenge.
• The majority of individuals affected by AD reside in low- and middle-income countries (LMICs).
• Current AD research predominantly focuses on high-income populations, neglecting the needs of a significant patient demographic.

Purpose of the Study:

• To address the ethical and scientific imperative for developing accessible Alzheimer's disease healthcare.
• To advocate for the creation of low-cost diagnostic tools for AD.
• To highlight the potential of recent technological advancements in enabling affordable AD diagnostics.

Main Methods:

• This study presents a scientific and ethical argument.
• It reviews the current landscape of AD research and diagnostics.
• It considers emerging technological possibilities for low-cost solutions.

Main Results:

• Technological breakthroughs indicate the feasibility of low-cost AD diagnostics.
• The increasing prevalence of AD in LMICs necessitates accessible healthcare solutions.
• Developing accessible diagnostics aligns with scientific and ethical responsibilities.

Conclusions:

• There is a clear scientific and ethical mandate to develop low-cost Alzheimer's disease diagnostics.
• Such developments are essential for improving healthcare in LMICs.
• Accessible diagnostics will benefit the entire field of Alzheimer's disease research and patient care.